These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 20225996

  • 21. Prophylaxis of migraine, transformed migraine, and cluster headache with topiramate.
    Mathew NT, Kailasam J, Meadors L.
    Headache; 2002 Sep; 42(8):796-803. PubMed ID: 12390644
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Conversion from valproic acid onto topiramate in adolescents and adults with epilepsy.
    Schreiner A, Stollhoff K, Ossig W, Unkelbach S, Lüer W, Bogdanow M, Schauble B, TOPMAT-EPY-403 investigators.
    Acta Neurol Scand; 2009 May; 119(5):304-12. PubMed ID: 19133865
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Efficacy and safety of topiramate in migraine prophylaxis: an open controlled randomized study comparing Sincronil and topamax formulations.
    Cosentino G, Paladino P, Maccora S, Indovino S, Fierro B, Brighina F.
    Panminerva Med; 2013 Sep; 55(3):303-7. PubMed ID: 24088805
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Topiramate 100 mg/day in migraine prevention: a pooled analysis of double-blind randomised controlled trials.
    Bussone G, Diener HC, Pfeil J, Schwalen S.
    Int J Clin Pract; 2005 Aug; 59(8):961-8. PubMed ID: 16033621
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Time course of adverse events most commonly associated with topiramate for migraine prevention.
    Láinez MJ, Freitag FG, Pfeil J, Ascher S, Olson WH, Schwalen S.
    Eur J Neurol; 2007 Aug; 14(8):900-6. PubMed ID: 17662012
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Comparison of the effect of topiramate and sodium valporate in migraine prevention: a randomized blinded crossover study.
    Shaygannejad V, Janghorbani M, Ghorbani A, Ashtary F, Zakizade N, Nasr V.
    Headache; 2006 Apr; 46(4):642-8. PubMed ID: 16643559
    [Abstract] [Full Text] [Related]

  • 40. Evaluation of carisbamate for the treatment of migraine in a randomized, double-blind trial.
    Cady RK, Mathew N, Diener HC, Hu P, Haas M, Novak GP, Study Group.
    Headache; 2009 Feb; 49(2):216-26. PubMed ID: 19222595
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.